Cyclo(Arg-Gly-Asp-D-Phe-Val);环(ARG-GLS-ASP-D-PHE-VAL) | 137813-35-5 |CYCLO(ARG-GLY-ASP-D-PHE-VAL)
正文部分
Cyclo(Arg-Gly-Asp-D-Phe-Val);环(ARG-GLS-ASP-D-PHE-VAL) | 137813-35-5 |CYCLO(ARG-GLY-ASP-D-PHE-VAL)
lianqin.ma@njpeptide.com |南京肽业 |18061682556 | QQ:2831069382 | 025-58361106-813
南京肽业同时提供下列多肽产品
| 多肽名称 | cas | 三字母缩写 |
| Cyclo(-Ala-Ala) |环(丙氨酰-丙氨酰) | 5845-61-4 | Cyclo(-Ala-Ala) |
| Cyclo(-Ala-Gln) | 268221-76-7 | CYCLO(-ALA-GLN) |
| Cyclo(-Ala-Glu) | 16364-36-6 | CYCLO(-ALA-GLU) |
| Cyclo(-Ala-Gly) | 4526-77-6 | CYCLO(-ALA-GLY) |
| Cyclo(-Ala-His) | 54300-25-3 | CYCLO(-ALA-HIS) |
| Cyclo(-Ala-Ser) | 155225-26-6 | CYCLO(-ALA-SER) |
| Cyclo(-Arg-Ala-Asp-D-Phe-Val) | 137813-36-6 | CYCLO(-ARG-ALA-ASP-D-PHE-VAL) |
| cyclo(Arg-Gly-Asp-D-Phe-Val) | | cyclo(Arg-Gly-Asp-D-Phe-Val) |
| cyclo(Arg-Gly-Asp-D-Phe-Val) | | cyclo(Arg-Gly-Asp-D-Phe-Val) |
| Cyclo(-Arg-Gly-Asp-D-Phe-Val) | | Cyclo(-Arg-Gly-Asp-D-Phe-Val) |
| Cyclo(Arg-Gly-Asp-D-Phe-Val);环(ARG-GLS-ASP-D-PHE-VAL) | 137813-35-5 | CYCLO(ARG-GLY-ASP-D-PHE-VAL) |
| Cyclo(-Asp(OMe)-Asp(OMe)) | | CYCLO(-ASP(OME)-ASP(OME)) |
| Cyclo(-Asp-Asp) | 35309-53-6 | CYCLO(-ASP-ASP) |
| Cyclo(-Asp-Gly) | 52661-97-9 | Cyclo(-Asp-Gly) |
| Cyclo(-Asp-Gly) | | Cyclo(-Asp-Gly) |
| Cyclo(-Asp-Phe) | | Cyclo(-Asp-Phe) |
| Cyclo(-D-Ala-D-Ala) | 23927-13-1 | CYCLO(-D-ALA-D-ALA) |
| Cyclo(-D-Ala-Pro) | | CYCLO(-D-ALA-PRO) |
| Cyclo(-D-Ala-Val) | | CYCLO(-D-ALA-VAL) |
| CYCLO(-D-ASP-PRO-ILE-LEU-D-TRP) | | CYCLO(-D-ASP-PRO-ILE-LEU-D-TRP) |
| Cyclo(-D-Glu-Ala-D-allo-Ile-Leu-D-Trp) | | Cyclo(-D-Glu-Ala-D-allo-Ile-Leu-D-Trp) |
| Cyclo(-D-His-Pro) | | CYCLO(-D-HIS-PRO) |
| Cyclo(-D-Leu-D-Pro) | | CYCLO(-D-LEU-D-PRO) |
| Cyclo(-D-Phe-His-Trp-Ala-Val-Gly-His-Leu-Leu) | | Cyclo(-D-Phe-His-Trp-Ala-Val-Gly-His-Leu-Leu)|Cyclo(-D-Phe-His-Trp-Ala-Val-Gly-His-Leu-Leu) |
| Cyclo(-D-Ser-Pro-D-Val-Leu-D-Trp) | 153982-38-8 | CYCLO(-D-SER-PRO-D-VAL-LEU-D-TRP) |
| Cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu) | 136553-81-6 | Cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu) |
| Cyclo(-D-Trp-Tyr) | | CYCLO(-D-TRP-TYR) |
| Cyclo(-Gln-Gly) | | CYCLO(-GLN-GLY) |
| Cyclo(-Gln-Trp-Phe-Gly-Leu-Met) | | Cyclo(-Gln-Trp-Phe-Gly-Leu-Met) |
| Cyclo(-Glu-Glu) | 16691-00-2 | CYCLO(-GLU-GLU) |
| Cyclo(-Glu-Gly) | | CYCLO(-GLU-GLY) |
| Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro-Ala) | | Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro-Ala) |
| Cyclo(-Gly-Asn-Trp-His-Gly-Thr-Ala-Pro-Asp)-Trp-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp-OH | 151308-48-4 | CYCLO(-GLY-ASN-TRP-HIS-GLY-THR-ALA-PRO-ASP)-TRP-VAL-TYR-PHE-ALA-HIS-LEU-ASP-ILE-ILE-TRP-OH |
| Cyclo(-Gly-Gly) | 4202-74-8 | Cyclo(-Gly-Gly) |
| Cyclo(-Gly-Gly) | | Cyclo(-Gly-Gly) |
| Cyclo(-Gly-His) | 15266-88-3 | CYCLO(-GLY-HIS) |
| Cyclo(-Gly-Leu) | | Cyclo(-Gly-Leu) |
| Cyclo(-Gly-Phe) | 10125-07-2 | CYCLO(-GLY-PHE) |
| Cyclo(-Gly-Pro) | 3705-27-9 | CYCLO(-GLY-PRO) |
| Cyclo(-Gly-Ser) | 52661-98-0 | CYCLO(-GLY-SER) |
| Cyclo(-Gly-Trp) | 7451-73-2 | CYCLO(-GLY-TRP) |
| Cyclo(-Gly-Tyr(PO3H2)-Val-Pro-Met-Leu) | 158778-21-3 | Cyclo(-Gly-Tyr(PO3H2)-Val-Pro-Met-Leu)|Cyclo(-Gly-Tyr(PO3H2)-Val-Pro-Met-Leu) |
| Cyclo(-GRGDSP) | | GRGDSP,NtoCcyclized |
| Cyclo(-His-D-Pro) | | CYCLO(-HIS-D-PRO) |
| Cyclo(-His-Phe) | 56586-95-9 | CYCLO(-HIS-PHE) |
| Cyclo(-His-Pro) | 53109-32-3 | Cyclo(-His-Pro)|Cyclo(-His-Pro) |
| CYCLO(-LEU-GLY) | 5845-67-0 | CYCLO(-GLY-LEU) |
| Cyclo(-Leu-Phe) | | CYCLO(-LEU-PHE) |
| Cyclo(-Leu-Pro) | 2873-36-1 | CYCLO(-LEU-PRO) |
| Cyclo(-Leu-Trp) | | CYCLO(-LEU-TRP) |
| Cyclo(-Met-Met) | 73037-51-1 | CYCLO(-MET-MET) |
| Cyclo(-Met-Pro) | | CYCLO(-MET-PRO) |
| Cyclo(-Phe-Phe) | 2862-51-3 | CYCLO(-PHE-PHE) |
| Cyclo(-Phe-Pro) | 3705-26-8 | Cyclo(-Phe-Pro) |
| Cyclo(-Phe-Pro) | | Cyclo(-Phe-Pro) |
| Cyclo(-Phe-Ser) | 35591-00-5 | CYCLO(-PHE-SER) |
| Cyclo(-Phe-Trp) | 82597-82-8 | CYCLO(-PHE-TRP) |
| Cyclo(-Pro-Gly)3 | 37783-51-0 | CYCLO(-PRO-GLY)3 |
| Cyclo(-Pro-Thr) | | CYCLO(-PRO-THR) |
| Cyclo(-Pro-Tyr) | 4549-02-4 | Cyclo(-Pro-Tyr) |
| Cyclo(-Pro-Tyr) | | Cyclo(-Pro-Tyr) |
| Cyclo(-Pro-Val) | 2854-40-2 | CYCLO(-PRO-VAL) |
| Cyclo(-RGDfK) | | Cyclo(-RGDfK) |
| Cyclo(-RGDyK) | | Cyclo(-RGDyK) |
| Cyclo(-Ser-Ser) | 23409-30-5 | CYCLO(-SER-SER) |
| Cyclo(-Ser-Tyr) | 21754-31-4 | CYCLO(-SER-TYR) |
| Cyclo(-Trp-Tyr) | | Cyclo(-Trp-Tyr) |
| CYCLO(TYR-ILE-GLN-ASN-ASU)-PRO-ARG-GLY-NH2 | 35375-13-4 | TYR-ILE-GLN-ASN-ASU-PRO-ARG-GLY-NH2 |
| Cyclo(-Val-Val) | 19943-16-9 | CYCLO(-VAL-VAL) |
| Cyclo[-FLLR-K(Dap)] | | Cyclo[-FLLR-K(Dap)] |
| Cyclo[-RGDfK(Ac-SCH2CO)] | | Cyclo[-RGDfK(Ac-SCH2CO)] |
定 购 方 式
请发送邮件至lianqin.ma@njpeptide.com或拨打电话025-58361106-813， 18061682556，QQ 2831069382联系我。
南京肽业提供高质量的多肽，定制服务！衍生物! 欢迎惠顾!
化妆品多肽：醋酸六胜肽，棕榈酸五胜肽，醋酸阿基瑞林，等
多肽试剂：Fmoc-Lys(Boc)-OH, Fmoc-Trp(Boc)-OH,Fmoc-Glu(otbu)-OH,Fmoc-Ala-OH，HBTU, EDC.HCl，CL-HOBT，TBTU, HOOBT，等
特殊多肽试剂：
Fmoc-Ser(HPO3Bzl)-OH; Fmoc-Thr(HPO3Bzl)-OH; Fmoc-Tyr(HPO3Bzl)-OH;
Fmoc-Lys(Dde)-OH ; Fmoc-Lys(Mtt)-OH; Fmoc-Lys(Mmt)-OH
Fmoc-Lys(Me)-OH; Fmoc-Lys(Me)2-OH; Fmoc-Lys(Me)3-OH
多肽药物：醋酸胸腺肽α1，醋酸亮丙瑞林，醋酸奥曲肽，醋酸依非巴特，醋酸辛卡立特，等
其他多肽: RGD,
联系人：马经理
南京肽业生物科技有限公司
Tel: 025-58361106-813
Mobile: 18061682556
Email: lianqin.ma@njpeptide.com
QQ: 2831069382
Cyclo(Arg-Gly-Asp-D-Phe-Val);环(ARG-GLS-ASP-D-PHE-VAL) | 137813-35-5 |CYCLO(ARG-GLY-ASP-D-PHE-VAL)
lianqin.ma@njpeptide.com |南京肽业 |18061682556 | QQ:2831069382 | 025-58361106-813
国内服务区域：·北京 天津·上海·重庆·西藏（拉萨等）·内蒙古（呼和浩特 等）·新疆·广西·宁夏·辽宁（大连 等）·吉林（长春 等）·黑龙江（哈尔滨等） ·河北（石家庄 等）·山西（太原 等）·陕西（西安 等）·江苏（南京、常州、无锡、苏州 等）·浙江（杭州、宁波、温州等）·福建（福州、厦门 等）·安徽（合肥等）·江西·山东（济南、青岛、烟台 等）·河南·湖北（武汉等）·湖南 ·广东（广州 深圳，珠海等）·海南·四川（成都 等）·贵州·云南·甘肃·青海·香港·澳门·台湾
Cyclo(Arg-Gly-Asp-D-Phe-Val);环(ARG-GLS-ASP-D-PHE-VAL) | 137813-35-5 |CYCLO(ARG-GLY-ASP-D-PHE-VAL)
lianqin.ma@njpeptide.com |南京肽业 |18061682556 | QQ:2831069382|025-58361106-813
温馨提示：不可用于临床ZL。
137813-35-5|CYCLO(ARG-GLY-ASP-D-PHE-VAL)|南京肽业
南京肽业|Cyclo（RGDFV）| cyclo （Arg-Gly-A...
CEF4,Influenza Virus NP (342-351)| RVLSFIKGTK lianqin.ma@njpeptide.com |南京肽业 |18061682556 | QQ:2831069382 | 025-58361106-813
了解详情
251316-98-0 Fmoc-L-allo-Ile-OH N-芴甲氧羰基-L-别异亮氨酸 南京肽业18061682550
了解详情
193885-59-5|(S)-N-Fmoc-Octylglycine|pan.chen@njpeptide.com
了解详情
